Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s Net Profit Rose 4.1% in First Quarter of 2023

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) (600332.SH) reported a net profit of 2 billion yuan in the first quarter of 2023, up 4.1% year-on-year.

Meanwhile, the company posted 21.6 billion yuan in revenue, up 5.3% year-on-year.

At the end of the reporting period, it had 73.7 billion yuan in total assets and 38.1 billion yuan in total liabilities, with a liability-to-asset ratio of 51.7%.